Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug Risk Assessment Needs IoM Report To Synthesize Research – CERTs

Jul 08 2002

• By The Pink Sheet

Related Content

FDA Plans Three Risk Management-Related Guidances Under PDUFA III

Jul 01 2002

DIA Annual Meeting, In Brief

Jul 01 2002

Medication Error Study By USP Will Examine Computerized Entry Systems

May 27 2002

CERTs Risk Management Agenda Includes Tikosyn Study, Workshops

Nov 12 2001

IMS Risk Management Tool Targets "High Risk" MDs: CERTs Conference

May 21 2001

FDA/PhRMA May Create Database Of Hepatotoxins

Nov 26 2001

Merck Builds Risk Management Into Drug Development; Hires FDA’s Honi

Jan 21 2002

FDA Postmarketing Strategy Draws On 1980 Melmon Commission Report

Feb 25 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window